Data as of 11:38am ET
| +0.06 / +1.87%|
The 3 analysts offering 12-month price forecasts for Tenax Therapeutics Inc have a median target of 10.50, with a high estimate of 12.00 and a low estimate of 7.00. The median estimate represents a +221.10% increase from the last price of 3.27.
The current consensus among 3 polled investment analysts is to Buy stock in Tenax Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.